Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis

Journal of Neuro-Oncology

Volumn 136, Issue 1, 2018, Pages 135-145

  Senders, Joeky T ^a,b   Goldhaber, Nicole H ^a   Cote, David J ^a   Muskens, Ivo S ^a,b   Dawood, Hassan Y ^a   De Vos, Filip Y F L ^b   Gormley, William B ^a   Smith, Timothy R ^a   Broekman, Marike L D ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Deep venous thrombosis; Intracranial hemorrhage; Primary malignant brain tumor; Pulmonary embolism; Venous thromboembolism

Indexed keywords

STEROID;

ADULT; ARTICLE; BODY MASS; BRAIN HEMORRHAGE; BRAIN SURGERY; BRAIN TUMOR; CANCER SURGERY; CARDIOVASCULAR RISK; COMORBIDITY; CRANIOTOMY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DRUG USE; FEMALE; FUNCTIONAL STATUS; GENDER; GROUPS BY AGE; HEALTH PROGRAM; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PREDICTOR VARIABLE; PREOPERATIVE CARE; REGISTER; REOPERATION; TOTAL QUALITY MANAGEMENT; VENOUS THROMBOEMBOLISM; CLINICAL TRIAL; MULTICENTER STUDY; TIME FACTOR;

BRAIN NEOPLASMS; CRANIOTOMY; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; QUALITY IMPROVEMENT; TIME FACTORS; VENOUS THROMBOEMBOLISM;

EID: 85031927872     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-017-2631-5     Document Type: Article

References (60)

1. Fadul C, Wood J, Thaler H, Galicich J, Patterson RH Jr, Posner JB (1988) Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology 38:1374–1379
2. Marcus LP, McCutcheon BA, Noorbakhsh A, Parina RP, Gonda DD, Chen C, Chang DC, Carter BS (2014) Incidence and predictors of 30-day readmission for patients discharged home after craniotomy for malignant supratentorial tumors in California (1995–2010). J Neurosurg 120:1201–1211. doi:10.3171/2014.1.JNS131264
3. Missios S, Kalakoti P, Nanda A, Bekelis K (2015) Craniotomy for glioma resection: a predictive model. World Neurosurg 83:957–964. doi:10.1016/j.wneu.2015.04.052
4. Simanek R, Vormittag R, Hassler M, Roessler K, Schwarz M, Zielinski C, Pabinger I, Marosi C (2007) Venous thromboembolism and survival in patients with high-grade glioma. Neuro Oncol 9:89–95. doi:10.1215/15228517-2006-035
5. Streiff MB, Ye X, Kickler TS, Desideri S, Jani J, Fisher J, Grossman SA (2015) A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors. J Neurooncol 124:299–305. doi:10.1007/s11060-015-1840-z
6. Smith TR, Lall RR, Graham RB, McClendon J Jr, Lall RR, Nanney AD, Adel JG, Zakarija A, Chandler JP (2014) Venous thromboembolism in high grade glioma among surgical patients: results from a single center over a 10 year period. J Neurooncol 120:347–352. doi:10.1007/s11060-014-1557-4
7. Khalil J, Bensaid B, Elkacemi H, Afif M, Bensaid Y, Kebdani T, Benjaafar N (2015) Venous thromboembolism in cancer patients: an underestimated major health problem. World J Surg Oncol 13:204. doi:10.1186/s12957-015-0592-8
8. Sartori MT, Della Puppa A, Ballin A, Saggiorato G, Bernardi D, Padoan A, Scienza R, d’Avella D, Cella G (2011) Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles. J Neurooncol 104:225–231. doi:10.1007/s11060-010-0462-8
9. Cote DJ, Smith TR (2016) Venous thromboembolism in brain tumor patients. J Clin Neurosci 25:13–18. doi:10.1016/j.jocn.2015.05.053
10. Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE (2006) Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med 119:60–68. doi:10.1016/j.amjmed.2005.06.058
11. Kimmell KT, Walter KA (2014) Risk factors for venous thromboembolism in patients undergoing craniotomy for neoplastic disease. J Neurooncol 120:567–573. doi:10.1007/s11060-014-1587-y
12. Edwin NC, Khoury MN, Sohal D, McCrae KR, Ahluwalia MS, Khorana AA (2016) Recurrent venous thromboembolism in glioblastoma. Thromb Res 137:184–188. doi:10.1016/j.thromres.2015.11.027
13. Chang SM, Parney IF, McDermott M, Barker FG 2nd, Schmidt MH, Huang W, Laws ER Jr, Lillehei KO, Bernstein M, Brem H, Sloan AE, Berger M, Glioma Outcomes I (2003) Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg 98:1175–1181. doi:10.3171/jns.2003.98.6.1175
14. Perry SL, Bohlin C, Reardon DA, Desjardins A, Friedman AH, Friedman HS, Vredenburgh JJ (2009) Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients. J Neurooncol 95:129–134. doi:10.1007/s11060-009-9911-7
15. Perry JR, Julian JA, Laperriere NJ, Geerts W, Agnelli G, Rogers LR, Malkin MG, Sawaya R, Baker R, Falanga A, Parpia S, Finch T, Levine MN (2010) PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. J Thromb Haemost 8:1959–1965. doi:10.1111/j.1538-7836.2010.03973.x
16. Farge D, Bounameaux H, Brenner B, Cajfinger F, Debourdeau P, Khorana AA, Pabinger I, Solymoss S, Douketis J, Kakkar A (2016) International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol 17:e452–e466. doi:10.1016/S1470-2045(16)30369-2
17. Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Bounameaux H, Buller HR (2013) International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost 11:56–70. doi:10.1111/jth.12070
18. Lyman GH, Bohlke K, Falanga A, American Society of Clinical Oncology (2015) Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Oncol Pract 11:e442-444. doi:10.1200/JOP.2015.004473
19. ®). Cancer-Associated Venous Thromboembolic Disease. Version 1.2014. National Comprehensive Cancer Network
20. Zwicker JI, Karp Leaf R, Carrier M (2016) A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation. J Thromb Haemost 14:1736–1740. doi:10.1111/jth.13387
21. Nghiemphu P, Green RM, Pope WB, Lai A, Cloughesy TF (2008) Safety of anticoagulation use and bevacizumab in patients with glioma. Neuro-Oncology 10:355–360. doi:10.1215/15228517-2008-009
22. Nabi S, Kahlon P, Bozorgnia F, Arshad A, Mikkelsen T, Donthireddy V (2016) Predictors of venous thromboembolism in patients with glioblastoma. Pathol Oncol Res 22:311–316. doi:10.1007/s12253-015-0008-7
23. Mantia C, Uhlmann EJ, Puligandla M, Weber GM, Neuberg D, Zwicker JI (2017) Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin. Blood. doi:10.1182/blood-2017-02-767285
24. Al Megren M, De Wit C, Al Qahtani M, Le Gal G, Carrier M (2017) Management of venous thromboembolism in patients with glioma. Thromb Res 156:105–108. doi:10.1016/j.thromres.2017.06.010
25. Lieber BA, Appelboom G, Taylor BE, Malone H, Agarwal N, Connolly ES Jr (2015) Assessment of the “July Effect”: outcomes after early resident transition in adult neurosurgery. J Neurosurg. doi:10.3171/2015.4.jns142149
26. McGirt MJ, Godil SS, Asher AL, Parker SL, Devin CJ (2015) Quality analysis of anterior cervical discectomy and fusion in the outpatient versus inpatient setting: analysis of 7288 patients from the NSQIP database. Neurosurg Focus 39:E9. doi:10.3171/2015.9.focus15335
27. Lieber BA, Appelboom G, Taylor BE, Lowy FD, Bruce EM, Sonabend AM, Kellner C, Connolly ES Jr, Bruce JN (2015) Preoperative chemotherapy and corticosteroids: independent predictors of cranial surgical-site infections. J Neurosurg. doi:10.3171/2015.4.jns142719
28. Lim S, Parsa AT, Kim BD, Rosenow JM, Kim JY (2015) Impact of resident involvement in neurosurgery: an analysis of 8748 patients from the 2011 American College of Surgeons National Surgical Quality Improvement Program database. J Neurosurg 122:962–970. doi:10.3171/2014.11.jns1494
29. McCutcheon BA, Ciacci JD, Marcus LP, Noorbakhsh A, Gonda DD, McCafferty R, Taylor W, Chen CC, Carter BS, Chang DC (2015) Thirty-day perioperative outcomes in spinal fusion by specialty within the NSQIP Database. Spine 40:1122–1131. doi:10.1097/brs.0000000000000599
30. Dasenbrock HH, Devine CA, Liu KX, Gormley WB, Claus EB, Smith TR, Dunn IF (2016) Thrombocytopenia and craniotomy for tumor: a National Surgical Quality Improvement Program analysis. Cancer. doi:10.1002/cncr.29984
31. Lieber BA, Han J, Appelboom G, Taylor BE, Han B, Agarwal N, Connolly ES Jr (2016) Association of steroid use with deep venous thrombosis and pulmonary embolism in neurosurgical patients: A National Database analysis. World Neurosurg. doi:10.1016/j.wneu.2016.01.033
32. Kim BD, Smith TR, Lim S, Cybulski GR, Kim JY (2014) Predictors of unplanned readmission in patients undergoing lumbar decompression: multi-institutional analysis of 7016 patients. J Neurosurg Spine 20:606–616. doi:10.3171/2014.3.spine13699
33. Dasenbrock HH, Liu KX, Devine CA, Chavakula V, Smith TR, Gormley WB, Dunn IF (2015) Length of hospital stay after craniotomy for tumor: a National Surgical Quality Improvement Program analysis. Neurosurg Focus 39:E12. doi:10.3171/2015.10.focus15386
34. Sellers MM, Merkow RP, Halverson A, Hinami K, Kelz RR, Bentrem DJ, Bilimoria KY (2013) Validation of new readmission data in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg 216:420–427. doi:10.1016/j.jamcollsurg.2012.11.013
35. Hackett NJ, De Oliveira GS, Jain UK, Kim JY (2015) ASA class is a reliable independent predictor of medical complications and mortality following surgery. Int J Surg 18:184–190. doi:10.1016/j.ijsu.2015.04.079
36. Abt NB, De la Garza-Ramos R, Olorundare IO, McCutcheon BA, Bydon A, Fogelson J, Nassr A, Bydon M (2016) Thirty day postoperative outcomes following anterior lumbar interbody fusion using the National Surgical Quality Improvement Program database. Clin Neurol Neurosurg 143:126–131. doi:10.1016/j.clineuro.2016.02.024
37. Lukasiewicz AM, Grant RA, Basques BA, Webb ML, Samuel AM, Grauer JN (2016) Patient factors associated with 30-day morbidity, mortality, and length of stay after surgery for subdural hematoma: a study of the American College of Surgeons National Surgical Quality Improvement Program. J Neurosurg 124:760–766. doi:10.3171/2015.2.jns142721
38. Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinski Y, Kruchko C, Barnholtz-Sloan JS (2016) CBTRUS Statistical Report: Primary brain and other central nervous system tumors diganosed int he United States in 2009–2013. Neuro-Oncology 18:v1–v75. doi:10.1093/neuonc/now207
39. Auguste KI, Quinones-Hinojosa A, Gadkary C, Zada G, Lamborn KR, Berger MS (2003) Incidence of venous thromboembolism in patients undergoing craniotomy and motor mapping for glioma without intraoperative mechanical prophylaxis to the contralateral leg. J Neurosurg 99:680–684. doi:10.3171/jns.2003.99.4.0680
40. Chaichana KL, Pendleton C, Jackson C, Martinez-Gutierrez JC, Diaz-Stransky A, Aguayo J, Olivi A, Weingart J, Gallia G, Lim M, Brem H (2013) Deep venous thrombosis and pulmonary embolisms in adult patients undergoing craniotomy for brain tumors. Neurol Res 35:206–211. doi:10.1179/1743132812y.0000000126
41. Chan AT, Atiemo A, Diran LK, Licholai GP, McLaren M, Black PM, Creager MA, Goldhaber SZ (1999) Venous thromboembolism occurs frequently in patients undergoing brain tumor surgery despite prophylaxis. J Thromb Thrombolysis 8:139–142
42. Cote DJ, Dubois HM, Karhade AV, Smith TR (2016) Venous thromboembolism in patients undergoing craniotomy for brain tumors: A U.S. Nationwide Analysis. Semin Thromb Hemost 42:870–876. doi:10.1055/s-0036-1592306
43. Dasenbrock HH, Liu KX, Chavakula V, Devine CA, Gormley WB, Claus EB, Smith TR, Dunn IF (2017) Body habitus, serum albumin, and the outcomes after craniotomy for tumor: a National Surgical Quality Improvement Program analysis. J Neurosurg 126:677–689. doi:10.3171/2016.2.jns152345
44. Nuno M, Carico C, Mukherjee D, Ly D, Ortega A, Black KL, Patil CG (2015) Association between in-hospital adverse events and mortality for patients with brain tumors. J Neurosurg 123:1247–1255. doi:10.3171/2014.10.jns141516
45. Goldhaber SZ, Dunn K, Gerhard-Herman M, Park JK, Black PM (2002) Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest 122:1933–1937
46. Smith TR, Nanney AD 3rd, Lall RR, Graham RB, McClendon J Jr, Lall RR, Adel JG, Zakarija A, Cote DJ, Chandler JP (2015) Development of venous thromboembolism (VTE) in patients undergoing surgery for brain tumors: results from a single center over a 10 year period. J Clin Neurosci 22(3):519–525. doi:10.1016/j.jocn.2014.10.003
47. Portillo J, de la Rocha IV, Font L, Braester A, Madridano O, Peromingo JA, Apollonio A, Pagan B, Bascunana J, Monreal M (2015) Venous thromboembolism in patients with glioblastoma multiforme: findings of the RIETE registry. Thromb Res 136:1199–1203. doi:10.1016/j.thromres.2015.10.043
48. Pan E, Tsai JS, Mitchell SB (2009) Retrospective study of venous thromboembolic and intracerebral hemorrhagic events in glioblastoma patients. Anticancer Res 29:4309–4313
49. Auer TA, Renovanz M, Marini F, Brockmann MA, Tanyildizi Y (2017) Ischemic stroke and intracranial hemorrhage in patients with recurrent glioblastoma multiforme, treated with bevacizumab. J Neurooncol. doi:10.1007/s11060-017-2467-z
50. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373–1379
51. Rolston JD, Han SJ, Bloch O, Parsa AT (2014) What clinical factors predict the incidence of deep venous thrombosis and pulmonary embolism in neurosurgical patients? J Neurosurg 121:908–918. doi:10.3171/2014.6.JNS131419
52. Strangman D (2009) Clinical Practice Guidelines for the management of adult gliomas: astrocytomas and oligodendrogliomas. Cancer Council Australia/Australian Cancer Network/Clinical Oncological Society of Australia
53. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ, American College of Chest Physicians Antithrombotic T, Prevention of Thrombosis P (2012) Executive summary: Antithrombotic Therapy and Prevention of Thrombosis. 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:7S-47S. doi:10.1378/chest.1412S3
54. Carman TL, Kanner AA, Barnett GH, Deitcher SR (2003) Prevention of thromboembolism after neurosurgery for brain and spinal tumors. South Med J 96:17–22. doi:10.1097/01.SMJ.0000047628.44490.B2
55. Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Somerfield MR, Falanga A, American Society of Clinical O (2015) Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society Of Clinical Oncology clinical practice guideline update 2014. J Clin Oncol 33:654–656. doi:10.1200/JCO.2014.59.7351
56. Prevention and treatment of venous thromboembolism (2013) International Consensus Statement 2013 Guidelines According to Scientific Evidence/Cardiovascular Disease Educational and Research Trust (UK)/European Venous Forum/North American Thrombosis Forum International Union of Angiology and Union Internationale du Phlebologie
57. Algattas H, Damania D, DeAndrea-Lazarus I, Kimmell KT, Marko NF, Walter KA, Vates GE, Jahromi BS (2017) Systematic review of safety and cost-effectiveness of venous thromboembolism prophylaxis strategies in patients undergoing craniotomy for brain tumor. Neurosurgery. doi:10.1093/neuros/nyx156
58. Alshehri N, Cote DJ, Hulou MM, Alghamdi A, Alshahrani A, Mekary RA, Smith TR (2016) Venous thromboembolism prophylaxis in brain tumor patients undergoing craniotomy: a meta-analysis. J Neurooncol 130:561–570. doi:10.1007/s11060-016-2259-x
59. Cote DJ, Dawood HY, Smith TR (2016) Venous thromboembolism in patients with high-grade glioma. Semin Thromb Hemost 42:877–883. doi:10.1055/s-0036-1592334
60. Salmaggi A, Simonetti G, Trevisan E, Beecher D, Carapella CM, DiMeco F, Conti L, Pace A, Filippini G (2013) Perioperative thromboprophylaxis in patients with craniotomy for brain tumours: a systematic review. J Neurooncol 113:293–303. doi:10.1007/s11060-013-1115-5